Concepedia

Armando García-Castillo

AG

Statistics

Publications

5

Citations

420

H-Index

5

Active since

2006

Affiliations

Brigham and Women's Hospital(Current)

Thrombolysis in Myocardial Infarction Study Group

Universidade de São Paulo

Pontificia Universidad Católica de Chile

Eisai (United States)

Armando García-Castillo is an author at Brigham and Women's Hospital specializing in clinical pharmacology, medicine, and clinical cardiology.

Publications per year

2006–2018

5

Publications

5

Cardiovascular Safety of Lorcaserin in Overweight or Obese Patients

Erin A. Bohula, Stephen D. Wiviott, Darren K. McGuire et al. · New England Journal of Medicine · 2018 · 264 citations · Full text

, , +15

Effect of lorcaserin on prevention and remission of type 2 diabetes in overweight and obese patients (CAMELLIA-TIMI 61): a randomised, placebo-controlled trial

Erin A. Bohula, Benjamin M. Scirica, Silvio E. Inzucchi et al. · The Lancet · 2018 · 95 citations · Full text

, , +14

Global outcomes of ST-elevation myocardial infarction: Comparisons of the Enoxaparin and Thrombolysis Reperfusion for Acute Myocardial Infarction Treatment-Thrombolysis In Myocardial Infarction study 25 (ExTRACT-TIMI 25) registry and trial

Benjamin A. Steinberg, Nazanin Moghbeli, Jacqueline L. Buros et al. · American Heart Journal · 2007 · 25 citations

, , +13

Mexican Registry of Acute Coronary Syndromes.

Armando García-Castillo, Carlos Jerjes‐Sánchez, Pedro Martínez Bermúdez et al. · PubMed · 2006 · 19 citations

, , +17

Edoxaban Versus Warfarin in Latin American Patients With Atrial Fibrillation

Ramón Corbalán, José Carlos Nicolau, José López‐Sendón et al. · Journal of the American College of Cardiology · 2018 · 17 citations · Full text

, , +13

1–5 of 5